Drugs: Licensing

(asked on 13th April 2017) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what factors will be measured to monitor patient access to treatment after the introduction of the NICE and NHS England joint changes to technology appraisals and highly specialised technologies reforms.


This question was answered on 20th April 2017

The National Institute for Health and Care Excellence (NICE) and NHS England will use standard systems already in place to measure access to treatments. In addition, NICE and NHS England have committed to review the impact of the changes to the arrangements for the assessment and adoption of new treatments three years after their implementation.

Reticulating Splines